Your browser doesn't support javascript.
loading
Very long chain acylcarnitines and lysophosphatidylcholines in screening of peroxisomal disease in children by tandem mass spectrometry.
Wang, Yanmin; Tian, Guoli; Ji, Wei; Wang, Simei; Zhang, Xiaofen.
Afiliación
  • Wang Y; 2. Department of Neurology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China.
  • Tian G; 2. Department of Neurology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China.
  • Ji W; 2. Department of Neurology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China.
  • Wang S; 2. Department of Neurology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China.
  • Zhang X; 2. Department of Neurology, Shanghai Children's Hospital, Shanghai Jiao Tong University, Shanghai 200040, China.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 50(4): 481-486, 2021 Aug 25.
Article en En | MEDLINE | ID: mdl-34704420
To investigate the value of very long chain acylcarnitine (VLCAC) and lysophosphatidylcholine (LPC) in screening of peroxisomal disease in children. Eighteen children with peroxisomal disease, including 14 cases of X-linked adrenoleukodystrophy (X-ALD group) and 4 cases of Zellweger syndrome (ZS group) diagnosed based on clinical symptoms, MRI and genetic tests were enrolled in the study; and 200 healthy children were selected as control group. Samples of dried blood spots were collected from all subjects, VLCAC and LPC in dried blood spots were extracted by solvent containing internal isotopic standards hexacosanoylcarnitine (H-C26) and C26:0 lysophosphatidylcholine (H-C26:0-LPC). The eicosanoylcarnitine (C20), docosanoylcarnitine (C22), tetracosanoylcarnitine (C24), hexacosanoylcarnitine (C26), C20:0 lysophosphatidylcholine (C20:0-LPC), C22:0 lysophosphatidylcholine (C22:0-LPC), C24:0 lysophosphatidylcholine (C24:0-LPC) and C26:0 lysophosphatidylcholine (C26:0-LPC) were detected by tandem mass spectrometry (MS/MS). The above 8 indicators and the ratios were compared among the groups using Kruskal-Wallis test and Mann-Whitney test; the contribution of each index to the disease were analyzed by partial least square method. Except C24:0-LPC/C20:0-LPC, there were significant differences in all indicators and ratios among all groups (<0.05 or <0.01). There were differences in most indicators and ratios between X-ALD group and the control group, as well as between ZS group and the control group, but there was no difference between the X-ALD group and the ZS group. PLS-DA analysis showed that the peroxisome disease group (including X-ALD group and ZS group) and the control group were able to be completely separated, and C26 had the highest variable importance for the projection (VIP) value. MS/MS detection of VLCAC and LPC can be used as a screening method for peroxisomal disease, and C26 may be a sensitive indicator for diagnosis.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lisofosfatidilcolinas / Espectrometría de Masas en Tándem Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Límite: Child / Humans Idioma: En Revista: Zhejiang Da Xue Xue Bao Yi Xue Ban Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lisofosfatidilcolinas / Espectrometría de Masas en Tándem Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Límite: Child / Humans Idioma: En Revista: Zhejiang Da Xue Xue Bao Yi Xue Ban Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: China